Terms: = Breast cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
611 results:
1. Integrative Bioinformatics Analysis Reveals Potential Target Genes and pten Signaling in breast cancer and Effect of Zingiber officinale (Ginger) and Allium sativum (Garlic) extract on It.
Sheybatzadeh K; Moshtaghie SAA; Shahanipour K; Golab F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):893-908. PubMed ID: 38546072
[TBL] [Abstract] [Full Text] [Related]
2. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the pten/PI3K/AKT/NF-κB pathway.
Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
[TBL] [Abstract] [Full Text] [Related]
3. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
5. Best of the year: Advanced breast cancer in 2023.
Schlam I; Chavez-MacGregor M
Breast; 2024 Apr; 74():103677. PubMed ID: 38401422
[TBL] [Abstract] [Full Text] [Related]
6. The interplay of pten and AKT nexus in breast cancer: a molecular perspective.
Kamal A; Awan AR; Rabbani M; Sheikh HR; Tayyab M; Firyal S; Khan IH; Wasim M
Mol Biol Rep; 2024 Feb; 51(1):345. PubMed ID: 38400870
[TBL] [Abstract] [Full Text] [Related]
7. Capivasertib: First Approval.
Shirley M
Drugs; 2024 Mar; 84(3):337-346. PubMed ID: 38388873
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.
Ido M; Fujii K; Mishima H; Kubo A; Saito M; Banno H; Ito Y; Goto M; Ando T; Mouri Y; Kousaka J; Imai T; Nakano S
BMC Cancer; 2024 Jan; 24(1):85. PubMed ID: 38229073
[TBL] [Abstract] [Full Text] [Related]
9. [News in breast oncology genetics for female and male population].
Taris N; Luporsi E; Osada M; Thiblet M; Mathelin C
Gynecol Obstet Fertil Senol; 2024 Mar; 52(3):149-157. PubMed ID: 38190969
[TBL] [Abstract] [Full Text] [Related]
10. p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Vanacker H; Treilleux I; Schiffler C; Bieche I; Campone M; Patsouris A; Arnedos M; Cottu PH; Jacquin JP; Dalenc F; Pinton A; Servant N; Attignon V; Rouleau E; Morel A; Legrand F; Jimenez M; Andre F; Bachelot T
Br J Cancer; 2024 Mar; 130(4):613-619. PubMed ID: 38182687
[TBL] [Abstract] [Full Text] [Related]
11. A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules.
Iragavarapu-Charyulu V; Shakya R; Robinson P; Guzmán E; Tyulmenkova A; Pino JL; Isgor C
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131223
[TBL] [Abstract] [Full Text] [Related]
12. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
13. Exploring Derivatives of Quinolizidine Alkaloid Sophoridine in the Design and Biological Mechanistic Evaluation of Histone Deacetylase Inhibitors against Triple-Negative breast cancer.
Dai L; Tan C; Wang H; Wang L; Zhang T; Zhi S; Yang Z; Zhao X; Li D
ChemMedChem; 2024 Jan; 19(2):e202300467. PubMed ID: 38031642
[TBL] [Abstract] [Full Text] [Related]
14. Immunoexpression of HER2 pathway related markers in HER2 invasive breast carcinomas treated with trastuzumab.
Franco AFDV; Malinverni ACM; Waitzberg AFL
Pathol Res Pract; 2023 Dec; 252():154917. PubMed ID: 37977031
[TBL] [Abstract] [Full Text] [Related]
15. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
16. Abrogation of ATR function preferentially augments cisplatin-induced cytotoxicity in pten-deficient breast cancer cells.
Zhao JL; Yang J; Li K; Chen Y; Tang M; Zhu HL; Nie CL; Yuan Z; Zhao XY
Chem Biol Interact; 2023 Nov; 385():110740. PubMed ID: 37802411
[TBL] [Abstract] [Full Text] [Related]
17. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
18. Cholesterol biogenesis is a pten-dependent actionable node for the treatment of endocrine therapy-refractory cancers.
Kaysudu I; Gungul TB; Atici S; Yilmaz S; Bayram E; Guven G; Cizmecioglu NT; Sahin O; Yesiloz G; Haznedaroglu BZ; Cizmecioglu O
Cancer Sci; 2023 Nov; 114(11):4365-4375. PubMed ID: 37706278
[TBL] [Abstract] [Full Text] [Related]
19. MYC Deregulation and pten Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative breast cancer.
Doha ZO; Wang X; Calistri NL; Eng J; Daniel CJ; Ternes L; Kim EN; Pelz C; Munks M; Betts C; Kwon S; Bucher E; Li X; Waugh T; Tatarova Z; Blumberg D; Ko A; Kirchberger N; Pietenpol JA; Sanders ME; Langer EM; Dai MS; Mills G; Chin K; Chang YH; Coussens LM; Gray JW; Heiser LM; Sears RC
Nat Commun; 2023 Sep; 14(1):5665. PubMed ID: 37704631
[TBL] [Abstract] [Full Text] [Related]
20. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
[TBL] [Abstract] [Full Text] [Related]
[Next]
